Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinician-level guide to managing adverse events from NAD precursors (NMN, NR, niacin), including dosing thresholds, monitoring parameters, drug interactions, and step-by-step mitigation protocols backed by primary-source evidence.
Read clinical reviewA practical, MD/PharmD-level guide to billing codes, prior-authorization strategies, and prescribing essentials for NAD precursor therapies including NMN, NR, and IV NAD+.
Read clinical reviewClinical monograph covering the NAD precursor drug class, including nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), niacin, and nicotinamide. Mechanisms, pharmacokinetics, trial data, dosing, safety, and prescribing considerations.
Read clinical reviewA physician- and pharmacist-level review of NAD precursor drug-drug interactions, including NMN, NR, niacin, and tryptophan. Covers mechanisms, DDI tables, dosing, and monitoring for clinical practice.
Read clinical reviewA prescriber-level monitoring bundle for NAD precursor therapy (NMN, NR, niacin, niacinamide) covering baseline labs, follow-up intervals, safety signals, and dose-adjustment triggers.
Read clinical reviewA clinician-level review of NAD precursor pharmacology, dosing, safety, and special-population considerations including pregnancy, renal impairment, oncology patients, and older adults. Evidence-based with primary citations.
Read clinical reviewA physician- and pharmacist-level review of NAD precursor drugs (NMN, NR, niacin), including evidence-based titration schedules, tapering protocols, dosing algorithms, and safety monitoring parameters.
Read clinical reviewA clinician-level guide to NMN, NR, niacin, and nicotinamide, comparing pharmacokinetics, tissue delivery, clinical evidence, and practical prescribing decisions for NAD precursor therapy.
Read clinical review